Arg-Gly-Glu-Ser acetate salt (C15-1217-946)

Catalog No.: C15-1217-946
Manufacturer No.: A5686-2MG
Manufacturer Name: Sigma-Aldrich
Quantity: 2
Unit of Measure: MG

Price: $222.86

List Price: $247.62

Amino Acid Sequence Arg-Gly-Glu-Ser Application Arg-Gly-Glu-Ser acetate salt has been used: as an integrin blocking peptide to study its effects on ciliary neurotrophic factor (CNTF) regulation in astroglioma cells as a control peptide to study its

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Amino Acid Sequence

Arg-Gly-Glu-Ser

Application

Arg-Gly-Glu-Ser acetate salt has been used:

as an integrin blocking peptide to study its effects on ciliary neurotrophic factor (CNTF) regulation in astroglioma cells
as a control peptide to study its effects on the binding of patient IgG to integrin αvβ6
as an integrin inhibitor peptide to study its effects on cell adhesion in Capsaspora owczarzaki cells

Biochem/physiol Actions

Arg-Gly-Glu-Ser peptide acts as an integrin-blocking peptide.

Inhibitor of platelet aggregation

UPC:: 51201901
Condition:: New
Weight:: 1.00 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: A5686-2MG

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."